Consumer Cyclical · Luxury Goods · NASDAQ · United States
$2.40-2.04%
Market cap $61MUpdated Oct 25, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: the share count could not be verified against reported earnings.
ACCE opinionAsiaStrategy Ordinary Shares (SORA)
Fair value (2 models)
Not available
ACCE price target
$1.84
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $2.40 at the close on 23 Oct 2026, 22:00 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
62
out of 100
P/E
4.8x
forward 0.0x
1-year return
-54.0%
Dividend yield
0.00%
AsiaStrategy Ordinary Shares in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
AsiaStrategy (SORA) sells luxury goods, and the figures we have show a company growing revenue 39.5% year over year on a $61M market cap, which puts it in the micro-cap tail of consumer cyclicals. The screen reads cheap at 4.9 times trailing earnings, but the gross margin of 2.7% and operating margin of -16.0% mean the earnings are not being generated by a durable pricing advantage, and the 81.3% ROE is inflated by a thin equity base rather than strong operations. The thesis rests on whether top-line growth can be converted into positive operating margins, which the current data does not yet show. A forward P/E of 0.0 reflects missing estimates rather than a signal, so we have no consensus to lean on. The name merits a deeper look only if the diligence can establish the source of the 39.5% growth and a credible path from negative to positive operating margin.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
high
Negative free cash flow
Free cash flow was -$555,010 while operating margin is -16.0%. The business is burning cash, and a 58.1% insider stake leaves little free float to absorb selling pressure.
moderate
Five-year revenue collapse
Revenue has a 5-year CAGR of -53.7%, so the recent +39.5% year-on-year rebound comes after a long contraction. The one-year figure is not yet a trend.
moderate
Earnings quality questionable
Net margin of +96.0% against a -16.0% operating margin and a +2.7% gross margin suggests the profit comes from non-operating items. The earnings jump of +5957.3% should be checked against what drove it.
AI research notes
AI-assisted·How I use AIWritten Oct 13, 2026 · figures from 2026-09-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 39.5% year over year in the latest 10-Q, a sharp reacceleration in the top line.
A 96.0% net margin and 81.3% return on equity show the business turns sales into profit very efficiently.
At a trailing P/E of 4.8x, the shares trade at a low multiple of recent earnings.
Why it could disappoint
Free cash flow over the last twelve months was negative at -$555,010, so the profits are not turning into cash.
Revenue has averaged -53.7% growth per year over five years, so the recent rebound is a short exception to a long decline.
The diluted share count rose 19.5% last fiscal year, diluting existing holders' stake in the company.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where SORA's valuation models land
Price
$2.40
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores
+Score history: how each score moved over time
Analysts
Wall Street consensus
No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
+Price-target low / average / high vs the current price, with implied upside
+Forward revenue and EPS consensus by fiscal year
+ACCE fair-value models lined up against the Street
Smart Money
PRO
In one line
Trades are only made public after a delay. We show the delay so you know how old the news is.